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a b s t r a c t
An 80-year-old male patient, presented with chest pain. ECG showed ST elevation in leads V2
to V4 and T wave inversion in leads V2-V6. Check angiogram revealed ostial LMCA 70% lesion
& mid-LAD 90% lesion and LCX proximal 80% lesion. Predilatation of LMCA lesion was done
with 2.0  12 mm NC Trek balloon and the LAD lesion with 2.0  12 mm and 2.5  08 mm (NC
Trek balloons). Prestenting IVUS (Intravascular ultrasound) was done with Atlantis SR pro
40 MHz 3.6Fr catheter. IVUS showed the LAD to have a minimal lumen area of 2.6 sq mm
with 90% ﬁbrotic plaque and a vessel size of 2.5 mm and the LMCA to have a minimal lumen
area of 8.8 sq mm with 70% ﬁbrotic plaque and vessel size of 3.8 mm. Mid-LAD stenting was
done with 2.5  28 mm Absorb Stent (BVS). Predilatation of LCX lesion was done with
2.5  08 mm NC Trek balloon. Then stenting was performed with 3.0  28 mm Absorb Stent
(BVS). Check angiogram showed edge dissection proximal to the BVS Stent which was
covered with 3.0  12 mm Xience Xpedtion Stent (DES). Then LMCA Stenting was done with
3.5  12 mm Absorb Stent. Post dilatation was done with 4.0  08 mm NC Trek balloon. Post
Stenting LMCA - LAD IVUS was done. LMCA and LAD Stents were well opposed without any
dissection or residual stenosis. TIMI III Flow was achieved in the ﬁnal results.
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journal homepage: www.elsevier.com/locate/ihjAn 80-year-old male patient, a known hypertensive and a
chronic smoker presented to the hospital with effort angina
for the last 3 months, and the pain has worsened since the last
3 days. ECG showed ST elevation in leads V2 to V4 and T wave
inversion in leads V2-V6. Coronary angiogram revealed
severe LMCA, LAD, and LCX disease. The LMCA was engaged
with EBU 7Fr guiding catheter and a check angiogram revealed
ostial LMCA 70% lesion, mid-LAD 90% lesion and LCX
proximal 80% lesion (Fig. 1A). The LAD lesion was crossed
with Sion blue wire and a 0.01400 BMW Elite wire was placed in
the LCX. Predilatation of LMCA lesion was done with* Corresponding author.
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2.0  12 mm and 2.5  08 mm (NC Trek balloons). Prestenting
IVUS (Intravascular ultrasound) was done with Atlantis SR pro
40 MHz 3.6Fr catheter. IVUS showed the LAD to have a
minimal lumen area of 2.6 sq mm with 90% ﬁbrotic plaque, a
vessel size of 2.5 mm, and the LMCA to have a minimal lumen
area of 8.8 sq mm with 70% ﬁbrotic plaque and vessel size of
3.8 mm (Fig. 1B). Mid-LAD stenting was done with
2.5  28 mm Absorb Stent (BVS) at 12 atms for 30 s and
redilatation was done with the same stent balloon at 14 atms
for 10 s (Fig. 2A). Postdilatation was done with 2.75  12 mmr B.V. All rights reserved.
Fig. 1 – (A) CAG-ostial LMCA 70% lesion, mid-LAD 90% lesion, and LCX proximal 80% lesion. (B) Prestenting IVUS-minimal
lumen area of LAD 2.6 sq mm with 90% fibrotic plaque; vessel size is 2.5 mm and LMCA is 8.8 sq mm with 70% fibrotic plaque
and vessel size is 3.8 mm.
Fig. 2 – (A) Mid-LAD Stenting done with 2.5 T 28 mm Absorb Stent (BVS). (B) LCX Stenting done with 3.0 T 28 mm Absorb Stent
(BVS). (C) Check angiogram showed edge dissection proximal to the (BVS) Stent. (D) Dissection covered with 3.0 T 12 mm
Xience Xpedtion Stent (DES). (E) LMCA Stenting done with 3.5 T 12 mm Absorb Stent. (F) Poststenting IVUS-well apposed
stent struts, no residual stenosis.
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) s 1 1 0 – s 1 1 2 S111NC Trek balloon. Predilatation of LCX lesion was done with
2.5  08 mm NC Trek balloon. Then stenting was performed
with 3.0  28 mm Absorb Stent (BVS) at 12 atms for 30 s and
redilatation was done with same stent balloon at 14 atms(Fig. 2B). Check angiogram showed edge dissection proximal
to the BVS Stent (Fig. 2C), which was covered with 3.0  12 mm
Xience Xpedtion Stent (DES) at 10 atms for 10 s and redilata-
tion was done with same stent balloon at 14 atms for 10 s
Fig. 3 – Final TIMI III flow.
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) s 1 1 0 – s 1 1 2S112(Fig. 2D). Then LMCA Stenting was done with 3.5  12 mm
Absorb Stent at 14 atms for 20 s and redilatation done with
same stent balloon at 18 atms for 15 s (Fig. 2E). Postdilatation
was done with 4.0  08 mm NC Trek balloon. Postdilatation of
mid-LAD was done with 2.75  10 mm NC trek balloon.
Poststenting LMCA–LAD IVUS was done (Fig. 2F). LMCA and
LAD Stents were well opposed without any dissection or
residual stenosis. The ﬁnal result was good with TIMI III Flow
and no complication (Fig. 3).
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